[Use of staphylococcal protein A for the detection of rubella virus IgM antibodies]. 1979

P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi

The ability of Staphylococcus aureus protein A to bind human serum immunoglobulin of different classes and the conditions which allow a selective reduction of IgG in comparison to other immunoglobulin classes were preliminarly studied. Working under standardized conditions, a recovery of 3.5% of the initial value for IgG, of 40-50% for IgM and of 70-75% for IgA was obtained. Rubella HI antibodies, before and after staphylococcus treatment, were titred in 88 sera collected from adult women at different times from hexantema and in 210 sera of 109 subjects exposed to eventual contamination. The results were compared with the ones obtained by means of sucrose density gradient centrifugation followed by titration of rubella HI antibodies in the fractions. The tests proved that HI antibodies titration, before and after serum treatment with staphylococcal protein A, can be used, as presumptive test, for the research of rubella specific IgM antibodies. In fact, all the sera, on which the presence of rubella IgM antibodies was proved by sucrose density gradient centrifugation, were also positive after staphylococcus treatment. In 15% of sera resulting positive for HI rubella antibodies after staphylococcus treatment, usually at low titer, the presence of specific IgM antibodies was not detected by serum fractionation on sucrose density gradient ("false positive" cases). The results of serological diagnosis, carried out by using treatment with staphylococcal protein A and serum fractionation on sucrose density gradient, matched the clinical-epidemiological data. Twenty-seven women, out of 28 examined during the first three months of pregnancy and for whom serological diagnosis of a "recent" rubella virus infection was negative, had normal children at normal time. Therefore only in one case a spontaneous abortion occurred for uncertain causes. Rubella virus was isolated from the embryo of a woman who interrupted pregnancy because asymptomatic rubella virus infection was serologically diagnosed in the second month.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006385 Hemagglutination Inhibition Tests Serologic tests in which a known quantity of antigen is added to the serum prior to the addition of a red cell suspension. Reaction result is expressed as the smallest amount of antigen which causes complete inhibition of hemagglutination. Hemagglutination Inhibition Test,Inhibition Test, Hemagglutination,Inhibition Tests, Hemagglutination,Test, Hemagglutination Inhibition,Tests, Hemagglutination Inhibition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012412 Rubella virus The type (and only) species of RUBIVIRUS causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. Measles Virus, German,German Measles Virus
D013205 Staphylococcal Protein A A protein present in the cell wall of most Staphylococcus aureus strains. The protein selectively binds to the Fc region of human normal and myeloma-derived IMMUNOGLOBULIN G. It elicits antibody activity and may cause hypersensitivity reactions due to histamine release; has also been used as cell surface antigen marker and in the clinical assessment of B lymphocyte function. Protein A,Protein A, Staphylococcal

Related Publications

P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
December 1987, Israel journal of medical sciences,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
January 1986, Zeitschrift fur medizinische Laboratoriumsdiagnostik,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
May 1975, Journal of clinical pathology,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
February 1995, Journal of clinical microbiology,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
July 1981, Journal of virological methods,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
April 1981, Acta pathologica et microbiologica Scandinavica. Section B, Microbiology,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
January 1982, Journal of virological methods,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
April 1987, Microbiologica,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
December 1978, British journal of experimental pathology,
P Crovari, and R Gasparini, and A Bono, and F Lusian, and G C Tassi
January 1981, Journal of medical virology,
Copied contents to your clipboard!